By If you or a loved one has recently received a cancer diagnosis in the UK, you have likely encountered a range of complex medical terms. Among the most promising are stereotactic radiotherapy, SABR, and SBRT. For men specifically—whether dealing with prostate, lung, or liver lesions—these technologies represent a seismic shift in how the NHS and private clinics treat solid tumours.
Gone are the days when radiotherapy meant daily hospital visits for weeks on end. Today, advanced precision treatments allow doctors to deliver a curative dose of radiation in just a handful of visits. This article explains exactly how these technologies work, what the difference between SABR and SBRT is, and what men in the UK can expect regarding access, side effects, and outcomes.
What Is Stereotactic Radiotherapy?
For patients, this means a much shorter treatment course. It effectively “ablates” (destroys) the tumour cells while significantly reducing damage to the healthy organs surrounding it, such as the bladder, rectum, or lungs.
What Is Stereotactic Ablative Radiotherapy (SABR)?
SABR is designed specifically for tumours located outside the brain (extracranial). It relies on advanced imaging—often 4D CT scans that track breathing motion—to ensure the radiation beam moves with the tumour. This is a common treatment for prostate, lung, kidney, and liver cancers across UK cancer centres like UCLH and Leeds.
What Is Stereotactic Body Radiation Therapy (SBRT)?
When you see SBRT mentioned in a research paper or a private clinic brochure, you can generally read it as “SABR.” Both terms involve using a linear accelerator or CyberKnife to fire high-energy x-rays from multiple angles, converging on the target.
SABR vs SBRT: Is There Any Difference?
| Feature | SABR (Stereotactic Ablative RT) | SBRT (Stereotactic Body RT) |
|---|---|---|
| Primary Terminology | UK & NHS Standard | International / US Standard |
| Treatment Goal | Ablative (destructive) | Ablative (destructive) |
| Dose per Fraction | Extremely High | Extremely High |
| Total Sessions | 1 to 8 (typically 3-5) | 1 to 8 (typically 3-5) |
| Technology | Linac, CyberKnife, MRIdian | Linac, CyberKnife, MRIdian |
| Clinical Outcome | Identical | Identical |
How Does Stereotactic Radiotherapy Work?
The success of this treatment relies heavily on immobilisation and image guidance. Before treatment begins, you will attend a “planning scan” appointment. Radiographers will create a custom mould or vacuum cushion to hold you in the exact same position every time. For lung cancers, they may use a mask or a belt to monitor breathing.
On treatment days, the linear accelerator rotates around you. The machine takes X-rays or CT scans before each beam is fired to ensure the tumour hasn’t moved. If it has (for example, due to a full bladder or breathing), the machine adjusts the couch position before firing.
Which Cancers in Men Can Be Treated with SABR or SBRT?
In the UK, SABR is currently a standard of care for several solid tumours common in men:
- Prostate Cancer: This is where the most significant advancements have occurred. Landmark trials (PACE and NRG GU‑005) have confirmed that SABR/SBRT is not only safe but often superior to longer courses regarding bowel and sexual function preservation.
- Lung Cancer: For early‑stage non‑small cell lung cancer (NSCLC) or oligometastatic disease to the lung, SABR offers high cure rates for patients who may be unfit for surgery. UCLH notes that this is a “more effective way of treating patients” compared to standard radiotherapy.
- Oligometastatic Disease: This refers to cancer that has spread to only a few (usually 3‑5) spots. SABR can be used to “zap” these spots. UK trials like the LUNAR trial are exploring combining SABR with new drugs to delay the need for hormone therapy.
- Liver and Kidney Tumours: SABR is increasingly used to treat primary renal cell carcinomas and liver metastases where surgery is risky.
Benefits of Stereotactic Radiotherapy for Men
- Convenience: Fewer hospital visits mean less time off work and less travel.
- Clinical Effectiveness: For prostate cancer, a 2025 phase III trial showed that SBRT patients had better preservation of sexual function and urinary control at two years compared to conventional radiotherapy patients.
- Low Incontinence Risk: A study presented by the PACE‑A trial indicated that only 6.5% of men treated with SBRT needed to use urinary pads at two years post‑treatment, compared to 50% who underwent surgery.
Potential Side Effects and Risks
Gastrointestinal (Bowel) Effects: While SABR spares the rectum better than conventional radiation, it can still cause mild temporary diarrhoea or rectal discomfort. Data from the PACE‑C trial for higher‑risk patients showed that while “grade 2” bowel issues were slightly higher in the SBRT group (17% vs 10%), severe (Grade 3+) toxicities were rare (1%).
Long-term Risks: There is a very small risk (less than 1-2%) of secondary cancer induction from radiation, though this risk is lower than with conventional radiotherapy because less total body volume is irradiated.
Is SABR Available on the NHS in the UK?
The NHS has invested heavily in Linac and MR‑Linac (Magnetic Resonance Linear Accelerator) technology to roll out SABR. However, availability is determined by eligibility criteria. For prostate cancer, the NHS will generally offer SABR to men with low, intermediate, or favourable high‑risk disease. Patients with very large prostates or specific bowel conditions may be advised to choose a different modality to ensure safety.
Private SABR and SBRT Treatment in the UK
For men seeking faster access or the very latest technology (such as the MRIdian machine, which uses MRI guidance for real‑time soft tissue tracking), private treatment is an option. Private providers like GenesisCare offer SABR/SBRT across multiple sites (London, Oxford, Nottingham, Birmingham). A first consultation with a specialist typically costs between £145 and £225. Private care often offers the advantage of “remote consultations” and potentially more flexible scheduling, though the clinical outcome for standard SABR on NHS vs Private is identical when using comparable machines.
What Happens During Treatment? (The Patient Journey)
- The Mask or Mould (Planning): You will attend a “mould room” appointment. For lung cancer, you may have a mesh mask made; for prostate, a vacuum cushion for your legs. You will also receive small permanent “tattoo” marks (the size of a freckle) for daily alignment.
- The Planning Scan: A CT scan (sometimes with a 4D component to track breathing) maps your internal anatomy. This data is sent to physicists who design the beam angles.
- The Treatment Session: You lie on the treatment couch. Radiographers align the lasers to your tattoos. They leave the room and fire the machine. The treatment itself is painless and sounds like a humming or buzzing. A session usually lasts 20‑30 minutes.
- Follow-up: You will have a follow‑up appointment (usually at 3 and 6 months) with your oncologist to review PSA levels or scan results.
Follow UK Health Insight for more tips!
Frequently Asked Questions
Dr. Samuel Kemp is a Consultant Physician at the Royal Brompton Hospital with specialist expertise in respiratory medicine, including lung cancer, COPD, and advanced interventional bronchoscopy.